INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 43h ago
HOUSE PTR3h ago
SEC 13F3h ago
ROBINHOOD CHAIN3h ago
Corporate insider
KA

Kreitzer Anatol

Chief Discovery OfficerCIK 0002021238

EDGAR filingsOpen in network
Disclosed transactions10
Buys / sells0 / 5
Max Insider Score39
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
39
KA
Kreitzer AnatolChief Discovery Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale
SELL$96K
12.2K sh
Oct 15, 2026Oct 16, 2026
traded Oct 15, 2026
+1dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    MapLight Therapeutics, Inc.Chief Discovery Officer · Jan 29, 2026
5
KA
Kreitzer AnatolChief Discovery Officer
MPLTMapLight Therapeutics, Inc.
Grant or award
A
—
6,020 sh
Aug 17, 2026
Aug 19, 2026
traded Aug 17, 2026
+2d
SEC FORM 4

Evidence

5
KA
Kreitzer AnatolChief Discovery Officer
MPLTMapLight Therapeutics, Inc.
Grant or award
A—
24.5K sh
Aug 17, 2026Aug 19, 2026
traded Aug 17, 2026
+2dSEC FORM 4

Evidence

19
KA
Kreitzer AnatolChief Discovery Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$242K
8,346 sh
Apr 27, 2026Apr 29, 2026
traded Apr 27, 2026
+2dSEC FORM 4

Evidence

26
KA
Kreitzer AnatolChief Discovery Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$867K
29.3K sh
Apr 27, 2026Apr 29, 2026
traded Apr 27, 2026
+2dSEC FORM 4

Evidence

19
KA
Kreitzer AnatolChief Discovery Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$239K
7,821 sh
Apr 27, 2026Apr 29, 2026
traded Apr 27, 2026
+2dSEC FORM 4

Evidence

39
KA
Kreitzer AnatolChief Discovery Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale
SELL$88K
3,316 sh
Apr 15, 2026Apr 17, 2026
traded Apr 15, 2026
+2dSEC FORM 4

Evidence

9
KA
Kreitzer AnatolChief Discovery Officer
MPLTMapLight Therapeutics, Inc.
Grant or award
A—
24.5K sh
Feb 5, 2026Feb 9, 2026
traded Feb 5, 2026
+4dSEC FORM 4

Evidence

9
KA
Kreitzer AnatolChief Discovery Officer
MPLTMapLight Therapeutics, Inc.
Grant or award
A—
6,020 sh
Feb 5, 2026Feb 9, 2026
traded Feb 5, 2026
+4dSEC FORM 4

Evidence

19
KA
Kreitzer AnatolChief Discovery Officer
MPLTMapLight Therapeutics, Inc.
Tax withholding
F$757K
42.1K sh
Jan 27, 2026Jan 29, 2026
traded Jan 27, 2026
+2dSEC FORM 4

Evidence